FDA Inspection 801960 — Patheon Softgels Inc

Patheon Softgels Inc — FEI 3001451366

The FDA completed an inspection of Patheon Softgels Inc on September 26, 2012 in High Point, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
High Point, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)